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Introduction:  Myxoﬁbrosarcoma  of the  thyroid  is exceptional:  a Medline  search  found  a single case  report.
We report  a new  case  which  raised  diagnostic  and therapeutic  problems.
Observation:  We  report  the  case  of  a 74-year-old  woman  who  presented  with  swelling  of  the  left  thyroid
lobe and  ipsilateral  cervical  lymphadenopathy.  Total  thyroidectomy  with  cervical  lymph-node  dissection
was performed.  Histological  analysis  diagnosed  myxoﬁbrosarcoma.  Evolution  was  marked  by  rapid  local
recurrence,  and  chemotherapy  based  on doxorubicin  and  ifosfamide  was introduced.
Discussion/conclusion:  Head  and  neck  myxoﬁbrosarcoma  is  rare.  MRI is  essential  and  should  always
precede  treatment.  Diagnosis  is  histological.  There  is  elevated  risk  of  local  recurrence  after  resection,
accompanied  by  worsening  tumor  grade,  whence  the  need  for accurate  diagnosis,  appropriate  treatment
and regular  MRI  follow-up.. Introduction
Myxoﬁbrosarcoma is one of the most common forms of sarcoma
n elderly subjects. Location is generally in the limbs [1], although
 few cases have been reported in the trunk (12%), retroperitoneal
pace and head and neck region (3%). The risk of local recurrence
fter resection is 50%, with tumor grade and prognosis worsen-
ng at each recurrence, with risk of metastasis [2]. We  report an
xceptional thyroid location which raised problems of diagnosis
nd treatment.
. Observation
A 74-year-old woman presented with left cervical swelling of
 months’ evolution. Clinical ENT examination found left lateral
ervical swelling in the thyroid projection area, extending up into
he submaxillary region. The mass was painful on palpation, soft,
odular, poorly contoured, 6 cm on the long axis, with ipsilateral
ubmandibular lymphadenopathies. Otherwise, ENT and somatic
xamination found no abnormalities. Radiologic assessment com-
rising ultrasound and cervical CT (Fig. 1a and b) found a tumoral
rocess in the left thyroid lobe with ipsilateral submandibular lym-
hadenopathies. Total thyroidectomy with tumor resection and
psilateral functional lymph-node dissection was  undertaken, and
evealed a nodular, poorly contoured mass with gelatinous and
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ﬁbrous areas. Immediate postoperative course was free of com-
plications.
Histology (Fig. 2) found malignant tumoral proliferation com-
prising areas of cells with highly nucleolated hyperchromatic
anisokaryotic nuclei and eosinophilic cytoplasms of varying abun-
dance, with myxoid remodeling and numerous vascular sections.
On immunohistochemistry (Fig. 3), the tumor cells were locally
positive for anti-EMA (epithelial membrane antigen) antibodies.
These morphological and immunohistochemical aspects indicated
high-grade myxoﬁbrosarcoma.
Extension assessment was  negative. Control MRI  at one month
found a tumoral process inﬁltrating the parotid region with
infratemporal and spinal extension suggestive of recurrence.
Six chemotherapy courses were instituted, comprising doxo-
rubicin (75 mg/m2) and ifosfamide (7.5 mg/m2) every 3 weeks,
supported by growth factors. Digestive and hematologic tolerance
was good, but left ventricle ejection fraction was  impaired (30%).
Post-chemotherapy assessment could not be performed, as the
patient was lost to follow-up.
3. Discussion
Soft-tissue sarcomas account for 1% of cancers in adults. Their
rarity, ubiquity and morphologic variability often raise problems of
diagnosis [1].Myxoﬁbrosarcoma is one of the most frequent sarcomas of the
limbs in elderly subjects of both sexes [2], but is rare in the head
and neck region, with only a few cases reported in the sphenoid
sinus, maxillary sinus, mandible and hypopharynx [3].
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Fig. 3. Histologic section showing focal marking for anti-EMA antibodies onig. 1. a: CT coronal image, showing the tumoral mass; b: CT axial image, showing
he tumoral mass.
MRI  is essential and should systematically precede treatment
1]. In the present case, the radiological assessment alone was
nsufﬁcient, falsely suggesting a large left thyroid nodule so that
omplementary examinations were not prescribed.
Diagnosis of soft-tissue sarcoma is essentially histopathological.
yxoﬁbrosarcoma was ﬁrst distinguished from malignant ﬁbrous
ig. 2. Histologic section with HE (hemalun-eosin) staining at low and high magni-
cation.immunohistochemistry.
histiocytoma 29 years ago by Angervall et al. on the basis of histo-
logical and immunohistochemical criteria [4]. Histologically, there
are often alternating myxoid and more cellular areas [4]. The pro-
portion of myxoid areas required to diagnose myxoﬁbrosarcoma
is controversial: some authors set the bar at 50% of tumor vol-
ume [5], while for others a 10% rate of typical myxoid areas is
enough [6]. The spindle-shaped or stellate cells have hyperchro-
matic nuclei. There is commonly mitosis. Myxoid areas show cells
with vacuolated cytoplasm suggestive of lipoblasts but which are in
fact mucin vacuoles, often poorly contoured and not deforming the
nucleus [7]. In the present case, histology indicated myxoﬁbrosar-
coma (with more than 50% myxoid areas); immunohistochemistry
found tumor cells were focally positive for anti-EMA antibodies.
Histologic grade is important for assessing metastatic potential
and the need for adjuvant treatment. It is founded on cell differen-
tiation, mitosis index and degree of tumoral necrosis [8] and should
not be performed before precise histologic characterization of the
sarcoma [1]. Myxoﬁbrosarcomas are classiﬁed in 3 grades [3]; the
present case was of high-grade myxoﬁbrosarcoma.
Regarding evolution, one half of cases show local recurrence
within 5 years, regardless of histologic grade or the depth of the
primary, and recurrence may  be found for up to 10 years. With
repeated recurrence, tumor grade worsens; 13% of intermediate
and high-grade tumors show metastasis [7,9].
These histologic and evolutive features call for precise diagnosis
and regular MRI  follow-up.
In the present case, total resection and lymph-node dissection
were performed. Given the histologic diagnosis and bad progno-
sis in case of incomplete resection, regular MRI  follow-up was
undertaken to enable early screening of any recurrence, such as did
indeed occur. Chemotherapy was  initiated, with doxorubicin and
ifosfamide. Unfortunately, the patient was  lost to follow-up after
6 cycles, having very probably died.
4. Conclusion
Myxoﬁbrosarcoma is a histological and clinical form of soft-
tissue sarcoma worth highlighting due to its misleading aspect
and particular prognosis. Ultrasound and CT are poorly contribu-
tive, often delaying diagnosis and complicating management. MRI
is essential for assessment, and should always precede biopsy. Ide-
ally, such cases should be discussed in regular multidisciplinary
team meetings of all those concerned by this type of pathology.
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